Sharda Cropchem Limited has informed the Exchange about Investor Presentation
SHARDACROP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sharda Cropchem reported exceptional Q4 and FY26 results driven by strong volume growth and margin expansion. Q4 FY26 revenue grew 13% to Rs. 2,065 crore, while full-year revenue increased 22% to Rs. 5,268 crore. Agrochemical volumes grew 13.3% in FY26 across Europe and LATAM regions. Gross margins improved significantly by 600 basis points to 35.9% in FY26, with EBITDA growing 69% to Rs. 1,040 crore. PAT more than doubled to Rs. 681 crore (highest ever), with EPS at Rs. 75.47. The company operates an asset-light model with 3,011 registrations procured globally, presence in 80+ countries, and zero debt. Working capital improved by 20 days to 98 days, while RoCE improved to 30.4%.
Strong operational performance with margin expansion and volume growth demonstrates successful execution of the company's asset-light business model. Management's guidance that gross margins will sustain at 35.9% in FY27 provides visibility on profitability, while the reduction in working capital and improvement in cash position (Rs. 702 crore) strengthens the balance sheet, which should be positive for the stock.